speb/financial-data huggingface dataset:
BION.SW cash_flow (quarterly, 2025-06-30) — Other Cash Paymentsfrom Operating Activities: -153793000.00
BION.SW cash_flow (quarterly, 2025-06-30) — Other Cash Receiptsfrom Operating Activities: 0.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Payables: 118000.00
BION.SW income_statement (quarterly, 2025-06-30) — Pretax Income: -100225000.00
BION.SW cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
BION.SW cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -3102000.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1873380000.00
BION.SW income_statement (quarterly, 2025-06-30) — Selling General And Administration: 6515000.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Share Issued: 55400000.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1842478000.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1842478000.00
BION.SW income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BION.SW income_statement (quarterly, 2025-06-30) — Tax Provision: 15000.00
BION.SW income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.09
BION.SW balance_sheet (quarterly, 2025-06-30) — Total Assets: 1844911000.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1842478000.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2433000.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 118000.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 774750.00
BION.SW balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 41982000.00
BION.SW income_statement (annual, 2025-12-31) — +Operating Expense: 8808000.00
BION.SW income_statement (quarterly, 2025-12-31) — +Operating Expense: 3139000.00
BION.SW income_statement (annual, 2025-12-31) — +Total Revenue: 587007000.00
BION.SW income_statement (quarterly, 2025-12-31) — +Total Revenue: 474845000.00
BION.SW balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 2680676000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 2680676000.00
BION.SW income_statement (annual, 2025-12-31) — Basic Average Shares: 54845193.00
BION.SW income_statement (annual, 2025-12-31) — Basic EPS: 10.54
BION.SW cash_flow (annual, 2025-12-31) — Beginning Cash Position: 458000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 81938000.00
BION.SW balance_sheet (annual, 2025-12-31) — Capital Stock: 11080000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Capital Stock: 11080000.00
BION.SW balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 98216000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 98216000.00
BION.SW balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 98216000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 98216000.00
BION.SW cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -98487000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
BION.SW cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: 309145000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: 16140000.00
BION.SW cash_flow (annual, 2025-12-31) — Changes In Cash: 105950000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Changes In Cash: 16140000.00
BION.SW cash_flow (annual, 2025-12-31) — Classesof Cash Payments: -1050163000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Classesof Cash Payments: -618150000.00
BION.SW cash_flow (annual, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 1359308000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 634290000.00
BION.SW balance_sheet (annual, 2025-12-31) — Common Stock: 11080000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Common Stock: 11080000.00
BION.SW cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -98487000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 0.00
BION.SW balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2778785000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2778785000.00
BION.SW cash_flow (annual, 2025-12-31) — Common Stock Issuance: 17884000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
BION.SW cash_flow (annual, 2025-12-31) — Common Stock Payments: -5037000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
BION.SW income_statement (annual, 2025-12-31) — Diluted Average Shares: 54845193.00
BION.SW income_statement (annual, 2025-12-31) — Diluted EPS: 10.54
BION.SW income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 578133000.00
BION.SW income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 471685000.00
BION.SW cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -8191000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 139000.00
BION.SW cash_flow (annual, 2025-12-31) — End Cash Position: 98216000.00
BION.SW cash_flow (quarterly, 2025-12-31) — End Cash Position: 98216000.00
BION.SW cash_flow (annual, 2025-12-31) — Financing Cash Flow: -203195000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
BION.SW cash_flow (annual, 2025-12-31) — Free Cash Flow: 309145000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 16140000.00
BION.SW income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 614143000.00
BION.SW income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 480768000.00
BION.SW income_statement (annual, 2025-12-31) — General And Administrative Expense: 6945000.00
BION.SW income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1655000.00
BION.SW income_statement (annual, 2025-12-31) — Interest Expense: 55000.00
BION.SW income_statement (quarterly, 2025-12-31) — Interest Expense: 0.00
BION.SW income_statement (annual, 2025-12-31) — Interest Income: 1321000.00
BION.SW income_statement (quarterly, 2025-12-31) — Interest Income: 423000.00
BION.SW cash_flow (annual, 2025-12-31) — Interest Paid Cff: -55000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: 0.00
BION.SW balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 2681873000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 2681873000.00
BION.SW balance_sheet (annual, 2025-12-31) — Investments And Advances: 2681873000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2681873000.00
BION.SW cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 17884000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
BION.SW cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -117500000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
BION.SW cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 12847000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
BION.SW income_statement (annual, 2025-12-31) — Net Income: 578133000.00
BION.SW income_statement (quarterly, 2025-12-31) — Net Income: 471685000.00
BION.SW income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 578133000.00
BION.SW income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 471685000.00
BION.SW income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 578133000.00
BION.SW income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 471685000.00
BION.SW income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 578133000.00
BION.SW income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 471685000.00
BION.SW income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 578133000.00
BION.SW income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 471685000.00
BION.SW income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 578133000.00
BION.SW income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 471685000.00
BION.SW income_statement (annual, 2025-12-31) — Net Interest Income: 1266000.00
BION.SW income_statement (quarterly, 2025-12-31) — Net Interest Income: 423000.00
BION.SW cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -117500000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
BION.SW cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -117500000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BION.SW cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 0.00
BION.SW cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
BION.SW balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2778785000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2778785000.00
BION.SW income_statement (annual, 2025-12-31) — Normalized Income: 578133000.00
BION.SW income_statement (quarterly, 2025-12-31) — Normalized Income: 471685000.00
BION.SW income_statement (annual, 2025-12-31) — Operating Revenue: 587007000.00
BION.SW income_statement (quarterly, 2025-12-31) — Operating Revenue: 474845000.00
BION.SW balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 55149250.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 55149250.00
BION.SW cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
BION.SW cash_flow (annual, 2025-12-31) — Other Cash Paymentsfrom Operating Activities: -1050128000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Other Cash Paymentsfrom Operating Activities: -618142000.00
BION.SW cash_flow (annual, 2025-12-31) — Other Cash Receiptsfrom Operating Activities: 1279000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Other Cash Receiptsfrom Operating Activities: 0.00
BION.SW income_statement (annual, 2025-12-31) — Other Operating Expenses: 443000.00
BION.SW balance_sheet (annual, 2025-12-31) — Other Payable: 4323000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Other Payable: 4323000.00
BION.SW balance_sheet (annual, 2025-12-31) — Payables: 4446000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Payables: 4446000.00
BION.SW income_statement (annual, 2025-12-31) — Pretax Income: 578199000.00
BION.SW income_statement (quarterly, 2025-12-31) — Pretax Income: 471706000.00
BION.SW balance_sheet (annual, 2025-12-31) — Receivables: 5514000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Receivables: 5514000.00
BION.SW cash_flow (annual, 2025-12-31) — Repayment Of Debt: -117500000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
BION.SW cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -5037000.00
BION.SW cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
BION.SW balance_sheet (annual, 2025-12-31) — Retained Earnings: 2775874000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 2775874000.00
BION.SW income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 653000.00
BION.SW income_statement (annual, 2025-12-31) — Selling General And Administration: 7598000.00
BION.SW income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2308000.00
BION.SW balance_sheet (annual, 2025-12-31) — Share Issued: 55400000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Share Issued: 55400000.00
BION.SW balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2778785000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2778785000.00
BION.SW balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2778785000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2778785000.00
BION.SW income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BION.SW income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BION.SW income_statement (annual, 2025-12-31) — Tax Provision: 66000.00
BION.SW income_statement (quarterly, 2025-12-31) — Tax Provision: 21000.00
BION.SW income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
BION.SW income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs:
BION.SW balance_sheet (annual, 2025-12-31) — Total Assets: 2785759000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Total Assets: 2785759000.00
BION.SW balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2778785000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2778785000.00
BION.SW balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 6974000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6974000.00
BION.SW balance_sheet (annual, 2025-12-31) — Total Tax Payable: 123000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 123000.00
BION.SW balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 250750.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 250750.00
BION.SW balance_sheet (annual, 2025-12-31) — Treasury Stock: 8169000.00
BION.SW balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 8169000.00
BION.SW income_statement (quarterly, 2026-03-31) — +Operating Expense: 4318000.00
BION.SW income_statement (quarterly, 2026-03-31) — +Total Revenue: -17039000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 2284474000.00
BION.SW income_statement (quarterly, 2026-03-31) — Basic Average Shares: 55149250.00
BION.SW income_statement (quarterly, 2026-03-31) — Basic EPS: -0.39
BION.SW cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 98216000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Capital Stock: 11080000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 354971000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 354971000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -124086000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Cash Flowsfromusedin Operating Activities Direct: 373707000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Changes In Cash: 249621000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Classesof Cash Payments: -914372000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Classesof Cash Receiptsfrom Operating Activities: 1288079000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Common Stock: 11080000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -124086000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2633322000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
BION.SW income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 55149250.00
BION.SW income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.39
BION.SW income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -21377000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 7134000.00
BION.SW cash_flow (quarterly, 2026-03-31) — End Cash Position: 354971000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -124086000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 373707000.00
BION.SW income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -18757000.00
BION.SW income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 4185000.00
BION.SW income_statement (quarterly, 2026-03-31) — Interest Expense: 0.00
BION.SW income_statement (quarterly, 2026-03-31) — Interest Income: 502000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: 0.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 2285682000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 2285682000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
BION.SW cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
BION.SW income_statement (quarterly, 2026-03-31) — Net Income: -21377000.00
BION.SW income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -21377000.00
BION.SW income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -21377000.00
BION.SW income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -21377000.00
BION.SW income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -21377000.00
BION.SW income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -21377000.00
BION.SW income_statement (quarterly, 2026-03-31) — Net Interest Income: 502000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
BION.SW cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
BION.SW cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 0.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2633322000.00
BION.SW income_statement (quarterly, 2026-03-31) — Normalized Income: -21377000.00
BION.SW income_statement (quarterly, 2026-03-31) — Operating Revenue: -17039000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 55149250.00
BION.SW cash_flow (quarterly, 2026-03-31) — Other Cash Paymentsfrom Operating Activities: -914372000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Other Payable: 1819000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Payables: 1963000.00
BION.SW income_statement (quarterly, 2026-03-31) — Pretax Income: -21357000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Receivables: 229000.00
BION.SW cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
BION.SW cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2630411000.00
BION.SW income_statement (quarterly, 2026-03-31) — Selling General And Administration: 4185000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Share Issued: 55400000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2633322000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2633322000.00
BION.SW income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BION.SW income_statement (quarterly, 2026-03-31) — Tax Provision: 20000.00
BION.SW income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
BION.SW balance_sheet (quarterly, 2026-03-31) — Total Assets: 2641182000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2633322000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7860000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 144000.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 250750.00
BION.SW balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 8169000.00
BIOS.BR income_statement (annual, 2021-12-31) — +Operating Expense: 878000.00
BIOS.BR income_statement (annual, 2021-12-31) — +Total Revenue: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Accounts Payable: 92000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Accounts Receivable: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -43000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 3969000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Amortization: 11000.00
BIOS.BR income_statement (annual, 2021-12-31) — Basic Average Shares: 66389.00
BIOS.BR income_statement (annual, 2021-12-31) — Basic EPS: -14.89
BIOS.BR cash_flow (annual, 2021-12-31) — Beginning Cash Position: 656000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 0.00
BIOS.BR cash_flow (annual, 2021-12-31) — Capital Expenditure: -207000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 2000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Capital Stock: 664000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 759000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 759000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Cash Equivalents: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Cash Financial: 759000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Change In Payable: -187000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Change In Receivables: 10000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Change In Working Capital: -177000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Changes In Cash: 103000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Common Stock: 664000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Common Stock Equity: -2670000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Construction In Progress: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Current Assets: 1124000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 2000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Current Debt: 1223000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 1225000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Current Liabilities: 1494000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Depreciation: 13000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 13000.00
BIOS.BR income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 13000.00
BIOS.BR income_statement (annual, 2021-12-31) — Depreciation Income Statement: 13000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Diluted Average Shares: 66389.00
BIOS.BR income_statement (annual, 2021-12-31) — Diluted EPS: -14.89
BIOS.BR income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: -984000.00
BIOS.BR income_statement (annual, 2021-12-31) — EBIT: -922000.00
BIOS.BR income_statement (annual, 2021-12-31) — EBITDA: -909000.00
BIOS.BR cash_flow (annual, 2021-12-31) — End Cash Position: 759000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Financing Cash Flow: 1170000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Free Cash Flow: -1067000.00
BIOS.BR income_statement (annual, 2021-12-31) — General And Administrative Expense: 265000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Goodwill: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Gross PPE: 56000.00
BIOS.BR income_statement (annual, 2021-12-31) — Interest Expense: 62000.00
BIOS.BR income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 62000.00
BIOS.BR income_statement (annual, 2021-12-31) — Interest Income: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Interest Income Non Operating: 0.00
BIOS.BR cash_flow (annual, 2021-12-31) — Interest Paid Cff: -33000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Interest Received Cfi: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Invested Capital: 826000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Investing Cash Flow: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 25000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 0.00
BIOS.BR cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
BIOS.BR cash_flow (annual, 2021-12-31) — Issuance Of Debt: 1391000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Land And Improvements: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Long Term Debt: 2273000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 2273000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 1391000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -181000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 43000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Minority Interest: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Minority Interests: 0.00
BIOS.BR cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
BIOS.BR cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Net Debt: 2737000.00
BIOS.BR income_statement (annual, 2021-12-31) — Net Income: -984000.00
BIOS.BR income_statement (annual, 2021-12-31) — Net Income Common Stockholders: -984000.00
BIOS.BR income_statement (annual, 2021-12-31) — Net Income Continuous Operations: -984000.00
BIOS.BR income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: -984000.00
BIOS.BR income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: -984000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: -877000.00
BIOS.BR income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: -984000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Net Interest Income: -107000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 1210000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 1210000.00
BIOS.BR income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: -107000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Net PPE: 26000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Net Tangible Assets: -2670000.00
BIOS.BR income_statement (annual, 2021-12-31) — Normalized EBITDA: -909000.00
BIOS.BR income_statement (annual, 2021-12-31) — Normalized Income: -984000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Operating Cash Flow: -1067000.00
BIOS.BR income_statement (annual, 2021-12-31) — Operating Income: -878000.00
BIOS.BR income_statement (annual, 2021-12-31) — Operating Revenue: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 21310520.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Current Assets: 4000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Current Liabilities: -3000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Equity Interest: -1000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 23000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Other Non Cash Items: 8000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Non Current Assets: -13000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 65000.00
BIOS.BR income_statement (annual, 2021-12-31) — Other Operating Expenses: 84000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Payable: 118000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Properties: 13000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Receivables: 1273000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 1200000.00
BIOS.BR income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Payables: 210000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 34000.00
BIOS.BR income_statement (annual, 2021-12-31) — Pretax Income: -984000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Properties: 0.00
BIOS.BR cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: 0.00
BIOS.BR cash_flow (annual, 2021-12-31) — Purchase Of PPE: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Reconciled Depreciation: 13000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Repayment Of Debt: -181000.00
BIOS.BR income_statement (annual, 2021-12-31) — Research And Development: 619000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Retained Earnings: -7219000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Selling General And Administration: 265000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Share Issued: 21310520.00
BIOS.BR cash_flow (annual, 2021-12-31) — Stock Based Compensation: -99000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Stockholders Equity: -2670000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Tangible Book Value: -2670000.00
BIOS.BR income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Tax Provision: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Taxes Receivable: 361000.00
BIOS.BR cash_flow (annual, 2021-12-31) — Taxes Refund Paid: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Total Assets: 1162000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Total Capitalization: -397000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Total Debt: 3498000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: -2670000.00
BIOS.BR income_statement (annual, 2021-12-31) — Total Expenses: 878000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 3832000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 38000.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 2338000.00
BIOS.BR income_statement (annual, 2021-12-31) — Total Operating Income As Reported: -877000.00
BIOS.BR income_statement (annual, 2021-12-31) — Total Other Finance Cost: 45000.00
BIOS.BR income_statement (annual, 2021-12-31) — Total Unusual Items: 0.00
BIOS.BR income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BIOS.BR balance_sheet (annual, 2021-12-31) — Working Capital: -370000.00
BIOS.BR income_statement (annual, 2022-12-31) — +Operating Expense: 2319000.00
BIOS.BR income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Accounts Payable: 1990000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1036000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -48000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 4516000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
BIOS.BR income_statement (annual, 2022-12-31) — Basic Average Shares: 120132013.00
BIOS.BR income_statement (annual, 2022-12-31) — Basic EPS: -0.02
BIOS.BR cash_flow (annual, 2022-12-31) — Beginning Cash Position: 759000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1200000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Capital Expenditure: -5000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1232000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Capital Stock: 4774000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1846000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1846000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Cash Equivalents: 34000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Cash Financial: 1812000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Change In Payable: 175000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Change In Receivables: 44000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Change In Working Capital: 219000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Changes In Cash: 1087000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Common Stock: 4774000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3526000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Common Stock Issuance: 500000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Construction In Progress: 141000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Current Assets: 4626000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 232000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Current Debt: 7782000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 8014000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Current Liabilities: 10353000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Depreciation: 60000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 60000.00
BIOS.BR income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 18000.00
BIOS.BR income_statement (annual, 2022-12-31) — Depreciation Income Statement: 18000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 3000.00
BIOS.BR income_statement (annual, 2022-12-31) — Diluted Average Shares: 120132013.00
BIOS.BR income_statement (annual, 2022-12-31) — Diluted EPS: -0.02
BIOS.BR income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -2041000.00
BIOS.BR income_statement (annual, 2022-12-31) — EBIT: -2771000.00
BIOS.BR income_statement (annual, 2022-12-31) — EBITDA: -2711000.00
BIOS.BR cash_flow (annual, 2022-12-31) — End Cash Position: 1846000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1045000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Free Cash Flow: -1915000.00
BIOS.BR income_statement (annual, 2022-12-31) — General And Administrative Expense: 693000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Goodwill: 1802000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 19095000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 1036000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Gross PPE: 1468000.00
BIOS.BR income_statement (annual, 2022-12-31) — Interest Expense: 278000.00
BIOS.BR income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 278000.00
BIOS.BR income_statement (annual, 2022-12-31) — Interest Income: 3000.00
BIOS.BR income_statement (annual, 2022-12-31) — Interest Income Non Operating: 3000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Interest Paid Cff: -31000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Interest Received Cfi: 1000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Invested Capital: 26084000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Investing Cash Flow: 1952000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 0.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 12000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 500000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1026000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1000000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Long Term Debt: 14776000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 15776000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1026000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -424000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 12000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 77000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Minority Interest: -402000.00
BIOS.BR income_statement (annual, 2022-12-31) — Minority Interests: 1008000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 1956000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 500000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Net Debt: 20712000.00
BIOS.BR income_statement (annual, 2022-12-31) — Net Income: -2041000.00
BIOS.BR income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -2041000.00
BIOS.BR income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -3049000.00
BIOS.BR income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -2041000.00
BIOS.BR income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -2041000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -2318000.00
BIOS.BR income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -3049000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
BIOS.BR income_statement (annual, 2022-12-31) — Net Interest Income: -286000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 602000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 602000.00
BIOS.BR income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -286000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Net PPE: 1420000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -5000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -15569000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 0.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 68000.00
BIOS.BR income_statement (annual, 2022-12-31) — Normalized EBITDA: -2266000.00
BIOS.BR income_statement (annual, 2022-12-31) — Normalized Income: -1596000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1910000.00
BIOS.BR income_statement (annual, 2022-12-31) — Operating Income: -2319000.00
BIOS.BR income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 32340263.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Other Current Assets: 290000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Other Current Liabilities: -2000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Other Equity Interest: 1000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 17293000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Other Non Cash Items: -1000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 135000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 68000.00
BIOS.BR income_statement (annual, 2022-12-31) — Other Operating Expenses: 272000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Other Payable: 246000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Other Properties: 50000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Other Receivables: 253000.00
BIOS.BR income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Payables: 2236000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 44000.00
BIOS.BR income_statement (annual, 2022-12-31) — Pretax Income: -3049000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Properties: 0.00
BIOS.BR cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
BIOS.BR cash_flow (annual, 2022-12-31) — Purchase Of PPE: -5000.00
BIOS.BR income_statement (annual, 2022-12-31) — Reconciled Depreciation: 60000.00
BIOS.BR income_statement (annual, 2022-12-31) — Rent And Landing Fees: 10000.00
BIOS.BR income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 10000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Repayment Of Debt: -424000.00
BIOS.BR income_statement (annual, 2022-12-31) — Research And Development: 1030000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Retained Earnings: -5723000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Sale Of Business: 1956000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
BIOS.BR income_statement (annual, 2022-12-31) — Selling General And Administration: 693000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Share Issued: 32340263.00
BIOS.BR income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3526000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Tangible Book Value: -15569000.00
BIOS.BR income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BIOS.BR income_statement (annual, 2022-12-31) — Tax Provision: 0.00
BIOS.BR income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1201000.00
BIOS.BR cash_flow (annual, 2022-12-31) — Taxes Refund Paid: 0.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Total Assets: 29324000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Total Capitalization: 18302000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Total Debt: 23790000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3124000.00
BIOS.BR income_statement (annual, 2022-12-31) — Total Expenses: 2319000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 26200000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 24698000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 15847000.00
BIOS.BR income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -2318000.00
BIOS.BR income_statement (annual, 2022-12-31) — Total Other Finance Cost: 11000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Total Tax Payable: 0.00
BIOS.BR income_statement (annual, 2022-12-31) — Total Unusual Items: -445000.00
BIOS.BR income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -445000.00
BIOS.BR balance_sheet (annual, 2022-12-31) — Working Capital: -5727000.00
BIOS.BR income_statement (annual, 2022-12-31) — Write Off: 0.00
BIOS.BR income_statement (annual, 2023-12-31) — +Operating Expense: 7040000.00
BIOS.BR income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Accounts Payable: 3594000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Accounts Receivable: 153000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -370000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 5720000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
BIOS.BR income_statement (annual, 2023-12-31) — Basic Average Shares: 136932018.00
BIOS.BR income_statement (annual, 2023-12-31) — Basic EPS: -0.21
BIOS.BR cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1846000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 921000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1125000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Capital Stock: 6275000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 117000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 117000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Cash Equivalents: 35000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Cash Financial: 82000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Change In Payable: 1634000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Change In Receivables: 55000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Change In Working Capital: 1689000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Changes In Cash: -1729000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Common Stock: 6275000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Common Stock Equity: -22912000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Common Stock Issuance: 1500000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Construction In Progress: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Current Assets: 1846000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 358000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Current Debt: 11463000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 11821000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Current Liabilities: 15844000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Depreciation: 243000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 243000.00
BIOS.BR income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 44000.00
BIOS.BR income_statement (annual, 2023-12-31) — Depreciation Income Statement: 44000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 0.00
BIOS.BR income_statement (annual, 2023-12-31) — Diluted Average Shares: 136932018.00
BIOS.BR income_statement (annual, 2023-12-31) — Diluted EPS: -0.21
BIOS.BR income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -28778000.00
BIOS.BR income_statement (annual, 2023-12-31) — EBIT: -27509000.00
BIOS.BR income_statement (annual, 2023-12-31) — EBITDA: -27266000.00
BIOS.BR cash_flow (annual, 2023-12-31) — End Cash Position: 117000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1735000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Free Cash Flow: -3470000.00
BIOS.BR income_statement (annual, 2023-12-31) — General And Administrative Expense: 1408000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Goodwill: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2989000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 153000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Gross PPE: 1067000.00
BIOS.BR income_statement (annual, 2023-12-31) — Interest Expense: 1519000.00
BIOS.BR income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1519000.00
BIOS.BR income_statement (annual, 2023-12-31) — Interest Income: 57000.00
BIOS.BR income_statement (annual, 2023-12-31) — Interest Income Non Operating: 57000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Interest Paid Cff: -28000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Interest Received Cfi: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Invested Capital: 4124000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Investing Cash Flow: 6000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 398000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 12000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 1500000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Issuance Of Debt: 1000000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 767000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Long Term Debt: 15573000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 16340000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 1000000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -413000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 12000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 90000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Minority Interest: 207000.00
BIOS.BR income_statement (annual, 2023-12-31) — Minority Interests: 243000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
BIOS.BR cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 1500000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Net Debt: 26919000.00
BIOS.BR income_statement (annual, 2023-12-31) — Net Income: -28778000.00
BIOS.BR income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -28778000.00
BIOS.BR income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -29021000.00
BIOS.BR income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -28778000.00
BIOS.BR income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -28778000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -7040000.00
BIOS.BR income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -29021000.00
BIOS.BR income_statement (annual, 2023-12-31) — Net Interest Income: -2716000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 587000.00